IP Library Granted Patent US 10,052,484
Granted Patent B2
US 10,052,484 · App. 15/701,253 · Granted Aug 21, 2018

Devices and methods for sleep apnea treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,052,484
App. No.
15/701,253
Granted
Aug 21, 2018
Kind
B2
Abstract

Devices and methods for improving the coupling between the soft palate and the genioglossus. This may be accomplished, for example, but shortening or stiffening the palatoglossal arch. Improved coupling between the soft palate and the genioglossus may be beneficial to a patient suffering from obstructive sleep apnea (OSA) as a stand-alone procedure, or in combination procedures and devices that cause anterior displacement of the tongue such as hypoglossal nerve stimulation, genioglossus advancement surgery, mandibular advancement surgery, mandibular advancement (oral) appliances, etc.

Claims (26)

1. A method of treating an upper airway condition of a patient, the method comprising:

implanting a stimulation device in the patient, the stimulation device configured to deliver an electrical stimulation signal to the patient's hypoglossal nerve to induce a first movement of the patient's upper airway tissue having a first magnitude corresponding to a first efficacy in treating the upper airway condition of the patient; and

implanting a fixation device in the patient's upper airway tissue, the fixation device having a first end secured to a first portion of upper airway tissue coupled to the tongue of the patient and an opposing second end secured to a second portion of upper airway tissue coupled to at least one of the patient's soft palate, palatopharyngeus, or palatoglossus,

wherein the implanting of the fixation device modifies the first movement to define a second movement of the patient's upper airway tissue having a second magnitude greater than the first magnitude, the second magnitude corresponding to a second efficacy in treating the upper airway condition of the patient.

2. The method of claim 1 , wherein the upper airway condition is an obstructive sleep apnea condition of the patient, and wherein at least one of the first and second movements mitigates the obstructive sleep apnea condition.

3. The method of claim 1 , wherein the upper airway condition includes a first tissue collapse at a first location within the patient's upper airway and a second tissue collapse at a second location within the patient's upper airway, wherein the first movement corresponds to a mitigation of the first tissue collapse, and wherein the second movement corresponds to a mitigation of both the first tissue collapse and the second tissue collapse.

4. The method of claim 1 , wherein the second movement includes a tightening of the patient's pharyngeal tissue.

5. The method of claim 4 , wherein the second movement includes a shortening of the patient's palatoglossus.

6. The method of claim 4 , wherein the second movement includes a shortening of the patient's palatopharyngeus.

7. The method of claim 4 , wherein the second movement includes a shortening of the patient's pharyngoepiglottic fold.

8. The method of claim 1 , wherein the first movement includes a contraction of the patient's genioglossus.

9. The method of claim 1 , the method further comprising implanting a sensing lead in the patient, wherein the stimulation device is further configured to sense inspirations of the patient via the sensing lead and deliver the electrical stimulation signal synchronized with the sensed inspirations of the patient.

10. The method of claim 1 , wherein the stimulation device is further configured to modify the electrical stimulation signal in response to receiving a signal from an external therapy controller.

11. A system for treating an upper airway condition of a patient, the system comprising:

a stimulation device configured to deliver an electrical stimulation signal to the patient's hypoglossal nerve to induce a first movement of the patient's upper airway tissue having a first magnitude corresponding to a first efficacy in treating the upper airway condition of the patient; and

a fixation device configured for implantation in the patient's upper airway tissue, the fixation device having a first end configured to be secured to a first portion of upper airway tissue coupled to the tongue of the patient and an opposing second end configured to be secured to a second portion of upper airway tissue coupled to at least one of the patient's soft palate, palatopharyngeus, or palatoglossus,

wherein the implantation of the fixation device modifies the first movement to define a second movement of the patient's upper airway tissue having a second magnitude greater than the first magnitude, the second magnitude corresponding to a second efficacy in treating the upper airway condition of the patient.

12. The system of claim 11 , wherein the upper airway condition is an obstructive sleep apnea condition of the patient, and wherein at least one of the first and second movements mitigates the obstructive sleep apnea condition.

13. The system of claim 11 , wherein the upper airway condition includes a first tissue collapse at a first location within the patient's upper airway and a second tissue collapse at a second location within the patient's upper airway, wherein the first movement corresponds to a mitigation of the first tissue collapse, and wherein the second movement corresponds to a mitigation of both the first tissue collapse and the second tissue collapse.

14. The system of claim 11 , wherein the second movement includes a tightening of the patient's pharyngeal tissue.

15. The system of claim 14 , wherein the second movement includes a shortening of the patient's palatoglossus.

16. The system of claim 14 , wherein the second movement includes a shortening of the patient's palatopharyngeus.

17. The system of claim 14 , wherein the second movement includes a shortening of the patient's pharyngoepiglottic fold.

18. The system of claim 11 , wherein the first movement includes a contraction of the patient's genioglossus.

19. The system of claim 11 , the system further comprising a sensing lead, wherein the stimulation device is further configured to sense inspirations of the patient via the sensing lead and deliver the electrical stimulation signal synchronized with the sensed inspirations of the patient.

20. The system of claim 11 , the system further comprising an external therapy controller, wherein the stimulation device is further configured to modify the electrical stimulation signal in response to receiving a signal from the external therapy controller.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
CHANGE OF NAME Recorded Jun 29, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 053306/0229 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2018
From: BOLEA, STEPHEN; TESFAYESUS, WONDIMENEH; BECK, JOHN; HOEGH, THOMAS; ATKINSON, ROBERT; HAUSCHILD, SIDNEY
To: APNEX MEDICAL, INC.
Reel/Frame 046405/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2018
From: APNEX MEDICAL, INC.
To: CYBERONICS, INC.
Reel/Frame 046405/0665 →